| Literature DB >> 21643694 |
Noriyoshi Iriyama1, Akira Horikoshi2, Toshitake Tanaka2, Yukio Hirabayashi3, Hitomi Kodaira2, Yoshihiro Hatta3, Jin Takeuchi3.
Abstract
A 34-year-old woman at 18 weeks of gestation during her third pregnancy was diagnosed with Hodgkin lymphoma stage IVA. She was treated with standard ABVD and showed good response. After three-and-a-half courses of ABVD, she spontaneously delivered a healthy baby girl at 41 weeks of gestation. She continued chemotherapy after delivery. A total of six courses of ABVD were given. Complete remission was obtained and has continued for 6 months post chemotherapy. Neither mother nor child developed any infections during the observation period. The child has also shown no physiological or developmental abnormalities. Here, we describe the feasibility and safety of the ABVD regimen for the treatment of Hodgkin lymphoma, and discuss the optimal treatment strategy.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21643694 DOI： 10.1007/s12185-011-0876-x
Source DB: PubMed Journal: Int J Hematol ISSN： 0925-5710 Impact factor: 2.490